Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs iShares Global Clean Energy ETF (ICLN) Price & Performance

AbCellera Biologics IncTrade
iShares Global Clean Energy ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs iShares Global Clean Energy ETF — how do they compare? AbCellera Biologics Inc trades at $9.53 (market cap $2.99B), while iShares Global Clean Energy ETF trades at $18.62. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.

ABCLICLN
Market Cap
$2.99B
Sector
Health
52-Week High
$9.76$23.75
52-Week Low
$2.78$13.66
Enterprise Value
$2.58B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.

The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.

iShares Global Clean Energy ETF

ICLN trades at $18.69, up 3.37% today, but technical indicators signal a bearish trend with moving averages showing 11 sell signals versus 2 buy signals. The ETF faces headwinds from higher expense ratios compared to traditional energy peers and regulatory uncertainty around renewable energy permits. Recent news highlights clean energy's 25% gains in 2026 but notes volatility concerns versus fossil fuel alternatives.

The outlook remains cautious as policy risks and competitive pressure from lower-cost energy ETFs challenge near-term performance. Long-term growth potential exists from global clean energy adoption, but investors face volatility and fee disadvantages relative to traditional energy funds.

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About iShares Global Clean Energy ETF

The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Read more on ICLN